Related Experiment Video
Updated: Apr 23, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Current developments for the oral delivery of heparin
1Department of Pharmaceutical Technology, Institute of Pharmacy, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany.
Developing oral heparin formulations remains crucial for improving patient compliance in anticoagulant therapy. This review explores strategies for effective oral unfractionated and low molecular weight heparins.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Biochemistry
Background:
- Anticoagulant therapy, including unfractionated heparin (UFH) and low molecular weight heparins (LMWH), is vital for treating and preventing thrombosis.
- Parenteral administration of UFH and LMWH limits patient compliance compared to oral medications.
- Existing oral anticoagulants have restricted indications, highlighting the need for oral heparin formulations.
Purpose of the Study:
- To review existing strategies for developing effective oral formulations of UFH and LMWH.
- To address the demand for improved oral anticoagulant options with established drugs.
Main Methods:
- Literature review of research strategies for oral heparin formulations.
- Analysis of approaches to achieve adequate anticoagulant effect via oral administration.
Main Results:
- Various strategies have been investigated to enable oral delivery of heparin.
- Challenges in oral bioavailability and efficacy of heparin formulations persist.
Conclusions:
- Developing oral heparin formulations is an ongoing area of research with significant clinical relevance.
- Successful oral heparin could enhance patient compliance and treatment options for thrombotic disorders.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Oral Drug Delivery Systems: Introduction
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Venous Thrombosis III: Interprofessional Care

